An animal model is a nonhuman species that can replicate the characteristics of a biological process, or a disease in humans. Biomedical research uses animal models. To target specific diseases in humans, genetic engineering is used to create different types of mice models. Biomedical research often uses mice model technology because they share many of the same characteristics as humans.
Increased investment in Biomedical Research Drives Demand for Mice Model Technology
The most important indicator of a country’s research landscape is its investment in biomedical research. Biomedical research spending has increased dramatically over the past decade in developed countries like the U.S., UK, and other nations. The majority of these investments go towards R&D for animal models.
The National Institutes of Health (NIH), which is the largest advocate for biomedical research, had a budget of approximately US$ 31 Bn in 2019. It was followed by the Bill & Melinda Gates Foundation and the Wellcome Trust (each with about US$ 1.08 Bn; 3.1%). Around 89.6%, or approximately US$ 32 Bn, of all grants for biomedical research, were awarded to recipient organizations in the U.S. The global market for mice-related technologies is expected to grow due to an increase in biomedical research funding.
To get a first-hand overview of the report, Request a Sample
Global Mice Model Technologies Market: Key Developments
July 2022 GemPharmatech announced it had signed a strategic licensing agreement with Charles River Laboratories, Inc. to distribute its next-generation NODCRISPR Prkdc Il2r Gamma (NCG mouse lines) in North America.
March 2022 Charles River Laboratories entered into an agreement to sell, distribute, market and breed the SRG rat from Hera BioLabs to the international preclinical research community. The SRG, (Sprague Dawley Rag2, Il2rg – “SRG”), is an immunodeficient rodent model that was created by knockout mutations in Rag2 and Il2r gamma genes. This results in mature T, B, and NK cells. The combination of severe immunodeficiency and a larger organism makes the SRG Rat an excellent alternative to mice for certain preclinical research applications.
Table: Years considered for the study:
|2028||Short Term Projection Year|
|2032||Long Term Projected Year|
Market segment by Type, covers
ES Cell Modification (Homologous Recombination)
Market segment by Application can be divided into
Academic and Research Facilities
Contract Research and Manufacturing Organizations
Market segment by players, this report covers
Charles River Laboratories
ingenious targeting laboratory
Ozgene Pty Ltd.
Taconic Biosciences, Inc.
THE JACKSON LABORATORY
Yale School of Medicine
University of North Carolina
University of Nebraska Medical Center
UMass Chan Medical School
University of Bonn
The University of Arizona
Regional Segment Analysis
North America (U.S., Canada, Mexico)
Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
Asia-Pacific (China, Japan, India, Rest of APAC)
South America (Brazil and the Rest of South America)
The Middle East and Africa (UAE, South Africa, Rest of MEA)
Frequently Asked Questions
How big was the global mice model technologies market in 2022?
How big will be the global mice model technologies market in 2031?
What was the CAGR of the global mice model technologies market from 2016-2021?
What will be the CAGR of the global mice model technologies market during the forecast period (2022–2031)?
Which are the prominent trends that affect the market growth?
What was the market share of the leading segment of the global mice model technologies market?
Which region will account for the major share of the global market during the forecast period?
Who are the prominent players in the global mice model technologies market?